Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Bevaciptin® Page last updated: 1 July 2022 Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 336KB) Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 52KB)